References
- Marshall B J, Goodwin C S, Warren J R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
- Borody T J. Possibilities for Helicobacter pylori suppression/ eradication. Eur J Gastroenterol Hepatol 1992; 4(Suppl 2)37–40
- Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6: 131–137
- Malfertheiner P, Pieramico O. Helicobacter pylori. The stomach, S Gustavsson, K Devinder, D Y Graham. Churchill Livingstone, New York 1992; 297–311
- Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–5
- Borsch G MA, Graham D Y. Helicobacter pylori. Pharmacology of peptic ulcer disease, M J Collen, S B Benjamin. Springer Verlag, Berlin, Heidelberg 1991; 107–47
- Graham D Y, Lew G M, Malaty H M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–6
- Maton P N, Sachs G, Wallmark B. Therapeutic use of omeprazole in man: pharmacology, efficacy, toxicity, and comparison with H2 receptor antagonists. Pharmacology of peptic ulcer disease, M J Collen, S B Benjamin. Springer Verlag, Berlin, Heidelberg 1991; 159–187
- Freston J W. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 121–140
- Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545–51
- Lambert H P, O'Grady F W. Antibiotic and chemotherapy, 6th ed. Churchill Livingstone, Edinburgh 1992
- Malfertheiner P, Nilius M. Bismuth salts. Helicobacter pylori: biology and clinical practice, C S Goodwin, B Worsley. CRC Press. 1993
- McNulty C AM, Dent J C. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents. Eur J Clin Microbiol 1988; 7: 566–9
- Goodwin C S, Blake P, Blincow E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloris. J Antimicrob Chemother 1986; 17: 309–14
- Bayerdörffer E, Ottenjann R. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 1988; 23(Suppl 142)93–100
- Glupczynski Y, Burette A, Nyst J F, DePrez C, DeKoster E, Deltenre M. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens. Acta Gastroenterol Belg 1988; 52: 329–37
- Hirschl A M, Hentschel E, Schutze K. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988; 23(Suppl 142)76–81
- Heatley R V. Review article: the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1992; 6: 291–303
- Glupczynski Y, Burette A. Acquired resistance to antibiotics: an underestimated cause of failure in the treatment of Helicobacter pylori infection 1990. Helicobacter pylori, H Menge, et al. Springer Verlag, Berlin, Heidelberg 1991; 163–70
- Becx M CJM, Janssen A JHM, Clasener H AL, DeKoning R W. Metronidazole-resistant Helicobacter pylori. Lancet 1990; 335: 539–40
- Rautelin H, Seppala K, Renkonen O-V, Vainio U, Kosunen T U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163–6
- Glupczynski Y, Burette A, DeKoster E. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976–7
- Haas C E, Nix D E, Schentag J J. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990; 34: 1637–41
- Goodwin C S, Marshall B J, Blincow E D, Wilson D H, Black-Bourne S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207–10
- O'Riordan T, Mathai E, Tobin E. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth sub-citrate. Gut 1990; 31: 999–1002
- Labenz J, Gyenes E, Riihl G H, Börsch G. Kurzzeittherapie mit hochdosiertem Omeprazol und Amoxicillin zur Helicobacter-pv/on-Eradikation. Eine Pilotstudie Med Klin 1992; 87: 118–9
- Bayerdörffer E, Mannes G A, Sommer A. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol 1992; 4: 697–702